Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy
Clinical trial NCT05990231 · UNKNOWN
Trial details
- NCT number
- NCT05990231
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-08-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.